CN1120337A - 咪唑衍生物的生产方法 - Google Patents

咪唑衍生物的生产方法 Download PDF

Info

Publication number
CN1120337A
CN1120337A CN94191674A CN94191674A CN1120337A CN 1120337 A CN1120337 A CN 1120337A CN 94191674 A CN94191674 A CN 94191674A CN 94191674 A CN94191674 A CN 94191674A CN 1120337 A CN1120337 A CN 1120337A
Authority
CN
China
Prior art keywords
base
alkyl group
low alkyl
hydrogen atom
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94191674A
Other languages
English (en)
Chinese (zh)
Inventor
山田弘美
宗贞清贵
洪桂子
谷口干雄
藤田芳司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CN1120337A publication Critical patent/CN1120337A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN94191674A 1993-03-19 1994-03-04 咪唑衍生物的生产方法 Pending CN1120337A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60067/93 1993-03-19
JP5060067A JPH06271576A (ja) 1993-03-19 1993-03-19 イミダゾール誘導体の製法

Publications (1)

Publication Number Publication Date
CN1120337A true CN1120337A (zh) 1996-04-10

Family

ID=13131379

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94191674A Pending CN1120337A (zh) 1993-03-19 1994-03-04 咪唑衍生物的生产方法

Country Status (7)

Country Link
EP (1) EP0689544A1 (ja)
JP (2) JPH06271576A (ja)
CN (1) CN1120337A (ja)
AU (1) AU6351994A (ja)
CA (1) CA2155573A1 (ja)
NZ (1) NZ263008A (ja)
WO (1) WO1994021641A1 (ja)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE146474T1 (de) * 1991-09-10 1997-01-15 Tanabe Seiyaku Co Imidazoindolizinderivate mit angiotensin-ii hemmwirkung
JPH06107661A (ja) * 1991-10-24 1994-04-19 Upjohn Co:The イミダゾール誘導体およびこれを有効成分とする医薬組成物

Also Published As

Publication number Publication date
JPH08508468A (ja) 1996-09-10
WO1994021641A1 (en) 1994-09-29
AU6351994A (en) 1994-10-11
JPH06271576A (ja) 1994-09-27
NZ263008A (en) 1996-12-20
EP0689544A1 (en) 1996-01-03
CA2155573A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
AU685939B2 (en) DC-89 derivative
DE2738477C2 (ja)
Jones et al. CARCINOGENICITY OF LACTONES: I. THE REACTION OF 4-METHYLBUTENO-AND 4-METHYLBUTANO-γ-LACTONES WITH PRIMARY AMINES
CS235053B2 (en) Method of alpha-6-desoxytetracycline and 6-desoxy-6-hydroxytetracycline production
CN1120337A (zh) 咪唑衍生物的生产方法
JP3771128B2 (ja) フェブリフジンおよびフェブリフジン化合物の新規合成方法
CN110078736A (zh) 吡唑并嘧啶衍生物、其制备方法及其应用
JP3446899B2 (ja) ハロピリジル−アザビシクロヘプタン誘導体の製造法および中間体
BRPI0408092B1 (pt) processo para preparar composto, e, composto
CN112538074A (zh) 一种溴莫尼定脱溴杂质的制备方法
Christensen et al. Preparation of Some trans-Aminomercaptofuranose Sugars1
CN107663165A (zh) 一种吲哚c‑3位置的c‑h键活化高效酯化的新方法
JPS596863B2 (ja) ５− アルフア− − ハロゲノアルカノイルカルボスチリルユウドウタイノセイゾウホウ
KR790001994B1 (ko) 6-데옥시테트라싸이클린의 제조방법
CN1038452A (zh) 吡咯嗪衍生物的制备方法
US20040053854A1 (en) Process for preparation of 4,5-Epoxymorphinan-6-oxyglucuronides
KR790001339B1 (ko) 6-데옥시테트라싸이클린의 제조방법
WO2024015861A1 (en) Methods of preparation of heterocyclic compounds
KR800000537B1 (ko) 아미노-페닐-에탄올아민의 제조방법
CN117486955A (zh) 一种非经典c-糖苷及其立体专一性合成方法和应用
CN114507180A (zh) 甲基取代的氮杂环化合物C(sp3)-H键自身脱氢烯基化的方法
JPH069642A (ja) ４−デソキシ−４−エピポドフィロトキシン誘導体及びその塩
CN1646452A (zh) 制备亚磷酸酯化(phosphitylated)化合物的方法
WO2003066549A2 (en) Synthesis of sulfamidates
JPH11246556A (ja) ４’−チオヌクレオシド誘導体およびその製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication